2-[(diphenylmethyl)sulfinyl]acetamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 2-[(diphenylmethyl)sulfinyl]acetamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
2-[(diphenylmethyl)sulfinyl]acetamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	S100A8 Gene (Entity type)	-0.010642867
2-[(diphenylmethyl)sulfinyl]acetamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	GNPDA1 Gene (Entity type)	-0.007503359
2-[(diphenylmethyl)sulfinyl]acetamide Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Hypersomnia Disease or Phenotype (Entity type)
2-[(diphenylmethyl)sulfinyl]acetamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	FABP7 Gene (Entity type)	-0.0073220446
2-[(diphenylmethyl)sulfinyl]acetamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	ELAC2 Gene (Entity type)	0.0062529994
2-[(diphenylmethyl)sulfinyl]acetamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	S100P Gene (Entity type)	-0.0102261705
2-[(diphenylmethyl)sulfinyl]acetamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	ZYX Gene (Entity type)	0.006700699
2-[(diphenylmethyl)sulfinyl]acetamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	AKAP12 Gene (Entity type)	0.0077380287
2-[(diphenylmethyl)sulfinyl]acetamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	ISG15 Gene (Entity type)	0.00718088
2-[(diphenylmethyl)sulfinyl]acetamide Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	rac-6-(7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide Compound (Entity type)	0.4126498401165008

2-[(diphenylmethyl)sulfinyl]acetamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
S100A8
Gene (Entity type)
-0.010642867

2-[(diphenylmethyl)sulfinyl]acetamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
GNPDA1
Gene (Entity type)
-0.007503359

2-[(diphenylmethyl)sulfinyl]acetamide
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Hypersomnia
Disease or Phenotype (Entity type)

2-[(diphenylmethyl)sulfinyl]acetamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
FABP7
Gene (Entity type)
-0.0073220446

2-[(diphenylmethyl)sulfinyl]acetamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
ELAC2
Gene (Entity type)
0.0062529994

2-[(diphenylmethyl)sulfinyl]acetamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
S100P
Gene (Entity type)
-0.0102261705

2-[(diphenylmethyl)sulfinyl]acetamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
ZYX
Gene (Entity type)
0.006700699

2-[(diphenylmethyl)sulfinyl]acetamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
AKAP12
Gene (Entity type)
0.0077380287

2-[(diphenylmethyl)sulfinyl]acetamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
ISG15
Gene (Entity type)
0.00718088

2-[(diphenylmethyl)sulfinyl]acetamide
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
rac-6-(7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide
Compound (Entity type)
0.4126498401165008

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.